Effect of Kaempferol against Biofilm Formation by Klebsiella pneumoniae Clinical Isolates

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Allah R.H.A.; Samir S.; Nasr S.M.; Ibrahim M.K.

Journal: Recent Patents on Biotechnology

Publisher: Bentham Science Publishers

Publication Date: August 2026

Volume / Issue: Volume 20 / Issue 4

Pages: 501–514

ISSN: 18722083

DOI: 10.2174/0118722083386487250804015300

Scopus: View on Scopus

PubMed: 40814887

Document Type: Article


Authors and Affiliations

Allah R.H.A., Microbiology Department, Faculty of Science, Ain Shams University, Cairo, Egypt; Samir S., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Nasr S.M., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt, School of Biotechnology, Badr University in Cairo, Cairo, Badr City, 11829, Egypt; Ibrahim M.K., Microbiology Department, Faculty of Science, Ain Shams University, Cairo, Egypt


Abstract

Introduction: Biofilm production is a key factor in the development of antibiotic resistance in multidrug-resistant Klebsiella pneumoniae (K. pneumoniae), a significant contributor to healthcare-associated infections (HAIs). Kaempferol, a flavonoid, is widely recognized for its ability to combat various microorganisms. Aim: Our goal is to assess the impact of kaempferol on K. pneumoniae biofilms by determining the level of gene expression for the biofilm-forming genes. Methods: Fifty K. pneumoniae isolates were studied. Different doses of kaempferol with a concentration range of 0.04 to 100% in Luria Bertani broth (LB) medium were incubated at 37°C for 24 h with forty-three K. pneumoniae strong and intermediate biofilm producers. The minimum inhibitory concentration (MIC) of kaempferol was determined. Molecular detection of the biofilm-forming genes (mrkA, pgaA, wbbM, and wzm) was performed on all isolates before and after kaempferol treatment at 0.5 x MIC. Results: Seven isolates out of 50 (14%) exhibited weak biofilm formation ability, 6 out of 50 (12%) were moderate producers, and 37 out of 50 (74%) were strong producers. The MIC values of kaempferol for K. pneumoniae ranged from 50% to 6.25% (p = 0.0003). The levels of expression of the studied genes were slightly decreased after treatment compared with their corresponding values before treatment. Discussion: Kaempferol has shown potential in disrupting biofilms by inhibiting key genes (mrkA, pgaA, wbbM, wzm) involved in adhesion and biofilm matrix synthesis, although its effect is moderate. In vitro testing revealed that kaempferol inhibits biofilm formation at varying concentrations depending on the bacterial strain, with gene expression downregulation indicating its interference in biofilm-related pathways. Patent related to this topic has been mentioned along the text. Conclusion: Based on current knowledge, few research studies have investigated the impact of kaempferol on K. pneumoniae biofilms. Our results show that its effect on the biofilms of this bacterium is moderate to weak. Further research is necessary to determine potential synergies with other treatments. 2026, Bentham Science Publishers


Keywords

antibiotics susceptibility; Biofilm; expression of genes; K. pneumoniae; kaempferol; quantitative real-time PCR; Anti-Bacterial Agents; Biofilms; Gene Expression Regulation, Bacterial; Humans; Kaempferols; Klebsiella pneumoniae; Microbial Sensitivity Tests; Patents as Topic; Antibiotics; Bacteria; Gene expression; Microwave integrated circuits; antiinfective agent; kaempferol derivative; Antibiotic susceptibilities; Biofilm formation; Clinical isolates; Expression of gene; Genes expression; Minimum inhibitory concentration; Real-time PCR; drug effect; gene expression regulation; genetics; growth, development and aging; human; isolation and purification; microbial sensitivity test; patent; physiology


Citation Information

Scopus Citations: 2


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region